Cargando…

The Effect of Different Formulations of Praziquantel in Reducing Worms in the Prepatent Period of Schistosomiasis in Murine Models

Schistosomiasis is a widely distributed parasitic disease and one of the most important neglected tropical diseases globally, for which Praziquantel® (PZQ) is the only available treatment. In this context, tests with new PZQ formulations become relevant for disease control. This study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paulino, Érica Tex, Ribeiro de Lima, Monique, Viçosa, Alessandra Lifsitch, da Silva, Cleber Hooper, Salomon, Claudio Javier, Real, Daniel Andrés, Leonardi, Dario, Mello Silva, Clélia Christina, de Moraes Neto, Antonio Henrique Almeida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184718/ https://www.ncbi.nlm.nih.gov/pubmed/35692307 http://dx.doi.org/10.3389/fpubh.2022.848633

Ejemplares similares

Anaphylactic reaction to praziquantel following schistosomiasis treatment
por: Vasconcelos, Géssica Almeida, et al.
Publicado: (2023)

Molecular detection of prepatent Schistosoma mansoni infection in Biomphalaria glabrata snail vectors
por: Casotti, Márcia Oliveira, et al.
Publicado: (2020)

New equipment optimized for emulsified vaccine prepation in the hospital
por: Ascarateil, Stephane, et al.
Publicado: (2013)

Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018)

Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment
por: Albertini, Beatrice, et al.
Publicado: (2019)

SvSXP: a Strongylus vulgaris antigen with potential for prepatent diagnosis
por: Andersen, Ulla V, et al.
Publicado: (2013)

Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis
por: Fukuchi, Takahiko, et al.
Publicado: (2019)

Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis
por: Alwan, Sevan N., et al.
Publicado: (2023)

Human Schistosomiasis Resistance to Praziquantel in China: Should We Be Worried?
por: Seto, Edmund Y. W., et al.
Publicado: (2011)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
por: HEGAZY, Laila Abdel Moniem, et al.
Publicado: (2018)

Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy
por: Silveira-Lemos, Denise, et al.
Publicado: (2013)

A rapid diagnostic test for schistosomiasis mansoni
por: Mello-Silva, Clélia Christina, et al.
Publicado: (2013)

Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn
por: Augusto, Ronaldo de Carvalho, et al.
Publicado: (2018)

Taste, A New Incentive to Switch to (R)-Praziquantel in Schistosomiasis Treatment
por: Meyer, Thorsten, et al.
Publicado: (2009)

Performance and Safety of Praziquantel for Treatment of Intestinal Schistosomiasis in Infants and Preschool Children
por: Sousa-Figueiredo, José C., et al.
Publicado: (2012)

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel
por: Walker, Joseph W., et al.
Publicado: (2020)

Authors' Response to “Praziquantel Could Be the Appropriate Choice for the Diagnostic Treatment of Schistosomiasis”
por: Koizumi, Yohei, et al.
Publicado: (2019)

The Role of Praziquantel in the Prevention and Treatment of Fibrosis Associated with Schistosomiasis: A Review
por: Niu, Xuehua, et al.
Publicado: (2022)

Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
por: Holtfreter, Martha C., et al.
Publicado: (2023)

Liver damage in schistosomiasis is reduced by adipose tissue-derived stem cell therapy after praziquantel treatment
por: Miranda, Vitor Hugo Simões, et al.
Publicado: (2020)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

Inhibition of Granulomatous Inflammation and Prophylactic Treatment of Schistosomiasis with a Combination of Edelfosine and Praziquantel
por: Yepes, Edward, et al.
Publicado: (2015)

Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
por: Bergquist, Robert, et al.
Publicado: (2017)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
por: Pearson, Mark S., et al.
Publicado: (2021)

Praziquantel and Upper Gastrointestinal Bleeding in Hepatic Schistosomiasis: A Quasi-Experimental Study
por: Opio, Christopher Kenneth, et al.
Publicado: (2020)

A diagnostic challenge for schistosomiasis japonica in China: consequences on praziquantel-based morbidity control
por: Zhou, Yi-biao, et al.
Publicado: (2011)

Development of the PraziCalc mobile device-app to calculate praziquantel dosage in the treatment of schistosomiasis
por: Viana, Agostinho Gonçalves, et al.
Publicado: (2018)

Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment
por: Melkus, Michael W., et al.
Publicado: (2020)

Parasitological Observation in Schoolchildren with Urogenital Schistosomiasis Following Treatment with Three Different Brands of Praziquantel
por: Jin, Yan, et al.
Publicado: (2020)

Efficacy of a low‐dose praziquantel and fenbendazole protocol in the treatment of asymptomatic schistosomiasis in dogs
por: Cridge, Harry, et al.
Publicado: (2021)

Efficacy of Praziquantel for the Treatment of Human Schistosomiasis in Ethiopia: A Systematic Review and Meta-Analysis
por: Hailegebriel, Tamirat, et al.
Publicado: (2021)

Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations
por: Boniatti, Janine, et al.
Publicado: (2021)

Development of a Method for the Quantification of Clotrimazole and Itraconazole and Study of Their Stability in a New Microemulsion for the Treatment of Sporotrichosis
por: Garcia Ferreira, Patricia, et al.
Publicado: (2019)

Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
por: Bustinduy, Amaya L., et al.
Publicado: (2016)

Ureteric obstruction secondary to schistosomiasis 2 years after praziquantel therapy: a case report
por: Olajide, Abimbola Olaniyi, et al.
Publicado: (2012)

Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal
por: Senghor, Bruno, et al.
Publicado: (2016)

Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis
por: Bergquist, Robert, et al.
Publicado: (2018)

437. Spatial Distribution of Schistosomiasis After Repeated Praziquantel Treatments in a Rural Community in Brazil
por: Terashima, Rafael Ponce, et al.
Publicado: (2018)

Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial
por: Wang, Xin-Yao, et al.
Publicado: (2019)

Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni
por: Eissa, Maha M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0239tf0vdq628pdb2a4thi7sf4